Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
150.7 USD | -0.93% | -0.51% | +56.55% |
Jun. 26 | Monetary policy is getting even more confusing | |
Jun. 26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.55% | 14.38B | |
+20.67% | 127B | |
+25.48% | 117B | |
+25.56% | 27.77B | |
-20.17% | 20.44B | |
-14.36% | 16.62B | |
-13.38% | 15.92B | |
-46.67% | 14.94B | |
+12.30% | 14.74B | |
+146.21% | 12.42B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Transcript : Sarepta Therapeutics, Inc. Presents at UBS Biopharma Conference 2023, Nov-09-2023 09